Table 1.
Baseline characteristics between the RIC group and control group in patients with acute ischemic stroke.
| All (N = 41) | RIC group (N = 19) | Control group (N = 22) | |
|---|---|---|---|
| Age, y (mean ± SD) | 63.1 ± 12.5 | 61.6 ± 10.9 | 64.3 ± 13.6 |
| Male, n (%) | 26 (63.4) | 11 (57.9) | 15 (68.1) |
| Baseline NIHSS score, median (IQR) | 6 (4–10) | 6.5 (4.3–7.8) | 6 (4–12) |
| Anterior circulation, n (%) | 28 (68.3) | 13 (68.4) | 15 (68.2) |
| Posterior circulation, n (%) | 13 (31.7) | 6 (31.6) | 7 (31.8) |
| Comorbidities, n (%) | |||
| Hypertension | 26 (63.4) | 8 (42.1) | 18 (81.8) |
| Diabetes Mellitus | 18 (43.9) | 9 (47.4) | 9 (40.9) |
| Atrial fibrillation | 4 (9.8) | 1 (5.3) | 3 (13.6) |
| Hyperlipidemia | 13 (31.7) | 5 (26.3) | 8 (36.4) |
| Previous stroke history | 9 (22.0) | 5 (26.3) | 4 (18.2) |
| Coronary artery disease | 5 (12.2) | 2 (10.5) | 3 (13.6) |
| Smoking | 16 (39.0) | 7 (36.8) | 9 (40.9) |
| Stroke etiology, n (%) | |||
| Large-artery atherosclerosis | 22 (53.7) | 11 (57.9) | 11 (50.0) |
| Cardioembolism | 3 (7.3) | 1 (5.3) | 2 (9.1) |
| Small-vessel occlusion and other causes | 16 (39.0) | 7 (36.8) | 9 (40.9) |
| Treatment, n (%) | |||
| IV tPA | 3 (7.3%) | 2 (10.5%) | 1 (4.5%) |
RIC, remote ischemic conditioning; SD, standard deviation; IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; IV tPA, intravenous tissue plasminogen activator.